CZ295675B6 - Způsob přípravy derivátu dihydro-2,3-benzodiazepinu a meziprodukty tohoto způsobu přípravy - Google Patents

Způsob přípravy derivátu dihydro-2,3-benzodiazepinu a meziprodukty tohoto způsobu přípravy Download PDF

Info

Publication number
CZ295675B6
CZ295675B6 CZ19952219A CZ221995A CZ295675B6 CZ 295675 B6 CZ295675 B6 CZ 295675B6 CZ 19952219 A CZ19952219 A CZ 19952219A CZ 221995 A CZ221995 A CZ 221995A CZ 295675 B6 CZ295675 B6 CZ 295675B6
Authority
CZ
Czechia
Prior art keywords
group
compound
formula
aryl
nitrophenyl
Prior art date
Application number
CZ19952219A
Other languages
Czech (cs)
English (en)
Other versions
CZ221995A3 (en
Inventor
Benjamin Alan Anderson
Marvin Martin Hansen
Jeffrey Thomas Vicenzi
David Lee Varie
Milton Joseph Junior Zmijewski
Original Assignee
Eli Lilly And Company Lilly Corporate Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/413,036 external-priority patent/US5665878A/en
Application filed by Eli Lilly And Company Lilly Corporate Center filed Critical Eli Lilly And Company Lilly Corporate Center
Publication of CZ221995A3 publication Critical patent/CZ221995A3/cs
Publication of CZ295675B6 publication Critical patent/CZ295675B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CZ19952219A 1994-08-31 1995-08-30 Způsob přípravy derivátu dihydro-2,3-benzodiazepinu a meziprodukty tohoto způsobu přípravy CZ295675B6 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US08/413,036 US5665878A (en) 1994-08-31 1995-03-28 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives

Publications (2)

Publication Number Publication Date
CZ221995A3 CZ221995A3 (en) 1996-03-13
CZ295675B6 true CZ295675B6 (cs) 2005-09-14

Family

ID=26970799

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ19952219A CZ295675B6 (cs) 1994-08-31 1995-08-30 Způsob přípravy derivátu dihydro-2,3-benzodiazepinu a meziprodukty tohoto způsobu přípravy

Country Status (21)

Country Link
US (3) US5919954A (enExample)
EP (1) EP0699677B1 (enExample)
JP (1) JP3481019B2 (enExample)
KR (1) KR100399518B1 (enExample)
CN (1) CN1086705C (enExample)
AT (1) ATE231867T1 (enExample)
AU (1) AU702658B2 (enExample)
BR (1) BR9503845A (enExample)
CA (1) CA2157234C (enExample)
CZ (1) CZ295675B6 (enExample)
DE (1) DE69529499T2 (enExample)
DK (1) DK0699677T3 (enExample)
ES (1) ES2189819T3 (enExample)
FI (1) FI113269B (enExample)
HU (1) HU223776B1 (enExample)
IL (1) IL115100A (enExample)
IN (1) IN190402B (enExample)
NO (1) NO312838B1 (enExample)
PL (3) PL188796B1 (enExample)
RU (1) RU2151149C1 (enExample)
TR (1) TR199501071A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010022856A (ko) * 1997-08-12 2001-03-26 사바 키스 ; 아틸라 만디 야노스 템페 ; 기울라 시미그 Ａｍｐａ/카이네이트 수용체 억제제로서의 1,3-디옥솔로/4,5-ｈ//2,3/벤조디아제핀 유도체
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
EP0918090A3 (en) * 1997-11-04 2002-08-28 Eli Lilly And Company Ketoreductase gene and protein from yeast
US20030219456A1 (en) * 2002-05-21 2003-11-27 Taing Ok Method of utilization of zygosaccharomyces rouxii
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
DE502005006892D1 (de) * 2005-12-05 2009-04-30 Deutsche Post Ag Verfahren zum Sortieren von Postsendungen und Vorrichtung mit einer Datenstruktur für einen Sortierplan
AU2006334172A1 (en) * 2005-12-30 2007-07-12 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
KR100841592B1 (ko) 2007-04-16 2008-06-26 한양대학교 산학협력단 벤조디옥솔 유도체와 이의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3748342A (en) * 1971-05-06 1973-07-24 Sandoz Ag Intermediates for preparing quinazolinones
US3794642A (en) * 1973-01-15 1974-02-26 Lilly Co Eli Oxidation of substituted methanes to the corresponding substituted methanols
DE2816475A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Isochroman-derivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4358041A (en) 1980-06-12 1982-11-09 Olin Corporation Powder-actuated tool with power adjustment and angle-fire control
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) 1986-08-15 1989-10-30 Gyogyszerkutato Intezet Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
DE68926417T2 (de) * 1988-02-12 1996-09-12 Daicel Chem Verfahren zur herstellung von optisch aktiven 2-hydroxysäureabkömmlingen
JP2679145B2 (ja) * 1988-09-02 1997-11-19 ダイセル化学工業株式会社 オキシケトンの製造法
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
JP3061422B2 (ja) * 1990-12-27 2000-07-10 ダイセル化学工業株式会社 光学活性（ｓ）−２−クロロ−１−フェニルプロパノールの製造法
JPH04271789A (ja) * 1991-01-10 1992-09-28 Takeda Chem Ind Ltd Ｄ−パントラクトンの製造方法
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
US6160133A (en) 2000-12-12
US5919954A (en) 1999-07-06
US5986114A (en) 1999-11-16
DE69529499D1 (de) 2003-03-06
IN190402B (enExample) 2003-07-26
JP3481019B2 (ja) 2003-12-22
HK1013818A1 (en) 1999-09-10
IL115100A0 (en) 1995-12-08
CA2157234A1 (en) 1996-03-01
AU3035595A (en) 1996-03-14
PL188796B1 (pl) 2005-04-29
TR199501071A2 (tr) 1996-06-21
PL310226A1 (en) 1996-03-04
FI954064A0 (fi) 1995-08-30
NO312838B1 (no) 2002-07-08
DK0699677T3 (da) 2003-04-22
ES2189819T3 (es) 2003-07-16
CN1086705C (zh) 2002-06-26
HU9502545D0 (en) 1995-10-30
FI113269B (fi) 2004-03-31
NO953396D0 (no) 1995-08-30
KR100399518B1 (ko) 2004-04-30
RU2151149C1 (ru) 2000-06-20
HUT72644A (en) 1996-05-28
KR960007595A (ko) 1996-03-22
PL190318B1 (pl) 2005-11-30
EP0699677A1 (en) 1996-03-06
ATE231867T1 (de) 2003-02-15
CN1123282A (zh) 1996-05-29
NO953396L (no) 1996-03-01
HU223776B1 (hu) 2005-01-28
CA2157234C (en) 2005-05-03
JPH0881468A (ja) 1996-03-26
BR9503845A (pt) 1996-04-16
DE69529499T2 (de) 2003-12-04
FI954064L (fi) 1996-03-01
EP0699677B1 (en) 2003-01-29
IL115100A (en) 2000-07-26
PL190640B1 (pl) 2005-12-30
AU702658B2 (en) 1999-02-25
CZ221995A3 (en) 1996-03-13

Similar Documents

Publication Publication Date Title
KR100399518B1 (ko) 디하이드로-2,3-벤조디아제핀유도체의입체선택적합성방법
US5665878A (en) Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives
NZ292417A (en) 7h-1,3-dioxolo[4,5-h] [2,3]-benzodiazepine derivatives and medicaments
CZ288679B6 (cs) Krystalická forma (R)-7-acetyl-5-(4-aminofenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo-[4,5-h][2,3]benzodiazepinu, způsob její přípravy a farmaceutický prostředek, který ji obsahuje
AU696243B2 (en) Physical form of a dihydro-2,3-benzodiazepine derivatives
HK1013818B (en) Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives
HK1013819B (en) Physical form of dihidro-2,3-benzodiazepine derivative
HK1013820B (en) Crystalline form of dihydro-2,3-benzodiazepine derivative

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20110830